Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-08-31
2009-02-03
Saeed, Kamal A (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S444000, C514S411000
Reexamination Certificate
active
07485663
ABSTRACT:
This invention relates to an improved process of preparing carvedilol, as well as a new crystalline hydrate and solvate and forms of carvedilol, processes for the manufacture thereof, and pharmaceutical compositions thereof.
REFERENCES:
patent: 4503067 (1985-03-01), Wiedemann et al.
patent: 4697022 (1987-09-01), Leinert
patent: 4824963 (1989-04-01), Leinert
patent: 4985454 (1991-01-01), Leinert
patent: 5071868 (1991-12-01), Leinert
patent: 5760069 (1998-06-01), Lukas-Laskey et al.
patent: 5902821 (1999-05-01), Lukas-Laskey et al.
patent: 6022562 (2000-02-01), Autant et al.
patent: 6365618 (2002-04-01), Swartz
patent: 6699997 (2004-03-01), Hildesheim et al.
patent: 6710184 (2004-03-01), Kor et al.
patent: 6730326 (2004-05-01), Beyer et al.
patent: 6777559 (2004-08-01), Scalone et al.
patent: 7056942 (2006-06-01), Hildesheim et al.
patent: 7169935 (2007-01-01), Scalone et al.
patent: 2002/0099223 (2002-07-01), Scalone et al.
patent: 2004/0127723 (2004-07-01), Sclaone et al.
patent: 2004/0152756 (2004-08-01), Chen et al.
patent: 2004/0171665 (2004-09-01), Kor et al.
patent: 2004/0198812 (2004-10-01), Bubendorf et al.
patent: 2004/0225132 (2004-11-01), Hildesheim et al.
patent: 2005/0240027 (2005-10-01), Brook et al.
patent: 2005/0277689 (2005-12-01), Brook et al.
patent: 2006/0148878 (2006-07-01), Bubendorf et al.
patent: 2006/0167077 (2006-07-01), Hercek et al.
patent: 2006/0270858 (2006-11-01), Chhabada et al.
patent: 2007/0027202 (2007-02-01), Kumar et al.
patent: 2007/0055069 (2007-03-01), Ramanjaneyulu et al.
patent: 2007/0112054 (2007-05-01), Knipp et al.
patent: 2007/0191456 (2007-08-01), Tarur et al.
patent: 2007/0197797 (2007-08-01), Harrington
patent: 1 259 071 (1989-09-01), None
patent: 0 127 099 (1984-12-01), None
patent: 0 127 099 (1987-05-01), None
patent: 0 918 055 (1999-05-01), None
patent: WO 99/05105 (1999-02-01), None
patent: WO 01/35938 (2001-05-01), None
patent: WO 01/66702 (2001-09-01), None
patent: WO 02/00216 (2002-01-01), None
patent: WO 03/005970 (2003-01-01), None
patent: WO 03/059807 (2003-07-01), None
patent: WO 2004/041783 (2004-05-01), None
patent: WO 2004/094378 (2004-11-01), None
patent: WO 2005/021504 (2005-03-01), None
patent: WO 2005/080329 (2005-09-01), None
patent: WO 2005/113502 (2005-12-01), None
patent: WO 2005/115981 (2005-12-01), None
patent: WO 2006/061364 (2006-06-01), None
patent: WO 2007/077111 (2007-07-01), None
patent: WO 2007/097504 (2007-08-01), None
Brittain, H.G. ed. “Polymorphism in Pharmaceutical Sciences,” 1999.
Eagleson, M. “Concise Encyclopedia Chemistry,” 1993, pp. 872-873.
Rouhi, A. M. “The Right Stuff,” Chemical & Engineering News, 2003, pp. 31-35.
“X-Ray Diffraction,” U.S. Pharmacopia #23, National Formulary #18 (1995), pp. 1843-1844.
Chen, et al, “Synthesis and Crystal Structure of Carvedilol,” Chinese J. Struct. Chem. (1998), vol. 17(5), pp. 325-328.
G.M. Wall, “Pharmaceutical Applications of Drug Crystal Studies”, Pharmaceutical Manufacturing, vol. 3, No. 2, pp. 33-42, Feb. 1986.
J.K. Haleblian and W. McCrone, “Pharmaceutical Applications of Polymorphism”, Journal of Pharmaceutical Sciences, vol. 58, No. 8, pp. 911-929, Jul. 1969.
J.K. Haleblian, “Characterization of Habits and Crystalline Modification of Solids and Their Pharmaceutical Applications”, Journal of Pharmaceutical Sciences, vol. 64, No. 8, pp. 1269-1288, Jul. 1975.
Pharmacopeial Forum, vol. 24, No. 1, pp. 5438-5441, Jan.-Feb. 1998.
Senderoff et al., “Synthesis of the Enantiomers and Three Racemic Metabolites of Carvedilol Labeled to High Specific Activity With Tritium”, Journal of Labeled Compounds and Radiopharmaceuticals, Dec. 1993, vol. 33, No. 12, pp. 1091-1105.
Chen, Wei-Min et al. “Synthesis and Crystal Structure of Carvediol” Jiegou Huaxue, vol. 17, No. 5, Sep. 1998, pp. 325-328 (abstract included).
Carey, Francis A. et al. “Advanced Organic Chemistry” Third Edition, Part A: Structure and Mechanisms; Plenum Press, pp. 232-239.
Offer of Information, dated Sep. 19, 2007, from corresponding Japanese Patent Application No. 2002-504998.
Japanese Office Action from corresponding Japanese Patent Application No. 2002-504998, mailed May 7, 2008, with English translation.
Experimental Chemistry, 20: Synthesis of Organic Chemistry II, 1956, pp. 497-498, edited by a legally incorporated foundation, Society of Chemistry of Japan, published by Maruzen Co., Ltd.
Experimental Chemistry (Continued), 2: Isolation and Purification, 1967, pp. 184-194, edited by a legally incorporated foundation, Society of Chemistry of Japan, published by Maruzen Co., Ltd.
Experimental Chemistry, 4thEdition, 1: Basic Procedures I, 1990, pp. 184-189, edited by a legally incorporated foundation, Society of Chemistry of Japan, published by Maruzen Co., Ltd.
Guidebook of Experimental Chemistry, 1984, pp. 130-131, edited by a legally incorporated foundation, Society of Chemistry of Japan, published by Maruzen Co., Ltd.
Manual of Pharmacology, 1989, 1stEdition, pp. 28, 76, 88, edited by Matsumoto Mitsuo, published by Nanzan-do Co., Ltd.
Aronhime Judith
Ben-Valid Shoshana
Dolitzky Ben-Zion
Finogueev Sergey
Hildesheim Jean
Coppins Janet L
Kenyon & Kenyon LLP
Saeed Kamal A
Teva Pharmaceutical Industries Ltd.
LandOfFree
Carvedilol does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Carvedilol, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Carvedilol will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4106797